Search

everythinglearnresearchcommunity

for

Search:↓

A man developed autoimmune symptoms after the Pfizer COVID-19 vaccine, highlighting the need for thorough vaccine safety checks.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Hair loss can indicate various health issues, including serious diseases, hormonal imbalances, and can significantly affect personal life and mental health.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

COVID-19 can cause various skin issues, including rashes and lesions.

COVID-19 doesn't make alopecia areata worse.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

University students in Egypt experienced high stress during COVID-19's third wave, with negative coping mechanisms being more common.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Older, obese people with many COVID-19 symptoms are more likely to suffer from severe long-term COVID-19 effects.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Dr. SKS hair booster serum effectively treats hair loss caused by COVID-19.

COVID-19 can cause hair loss and nail issues, with treatments available for these conditions.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

COVID-19 can cause skin problems in children.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 may cause temporary hair loss due to the body's immune response.